Shigematsu, Yasuyuki
Amori, Gulanbar
Kanda, Hiroaki
Takahashi, Yu
Takazawa, Yutaka
Takeuchi, Kengo
Inamura, Kentaro https://orcid.org/0000-0001-6444-3861
Article History
Received: 26 November 2021
Revised: 21 February 2022
Accepted: 26 March 2022
First Online: 23 April 2022
Declarations
:
: The study was approved by the Ethics Committee of Japanese Foundation for Cancer Research and the committee’s approval reference number is 2017-1136. Informed patient consent specific to this study was waived for this retrospective study.
: The authors declare no competing interests.